title: [Sacral neuromodulation: results of a monocentric study of 93 patients].
abstract: BACKGROUND
  Sacral nerve stimulation (NMS) is a therapeutic alternative for the treatment of urinary functional disorders as diverse as overactive bladder (OAB), urinary retention or pelvic pain syndromes. With the increasing use of NMS, we must deal with the postoperative management of this therapy.
  
  
  OBJECTIVE
  We report the results, postoperative adverse events and their management in our center.
  
  
  METHODS
  This is a retrospective single-center single-operator study of 93 patients who were tested for NMS between January 2005 and December 2013.
  
  
  RESULTS
  Of the 93 patients, 78 had a definitive implantation of the device for OAB (n=44), urinary retention (n=11), pain, interstitial cystitis (n=12), bladder hyperactivity and pain (n=8) or dysuria (n=3). The average follow-up was 38.86 months (2.06 to 88.3±28.9). Among patients with OAB, 75% had a clinical improvement greater than or equal to 50%, 11.3% were considered as cured. Among patients with urinary retention, 63.5% were improved. Painful patients were improved for 58.3% of them, 2 were considered as cured. We reported 3 early postoperative complications (2 local infections, 1 hematoma), and adverse events in 49 patients (multiple visits for parameter settings, revision of the device [n=38], explantation [n=14]).
  
  
  CONCLUSIONS
  Our results confirm the long-term effectiveness of NMS for the treatment of refractory overactive bladder, urinary retention, chronic pelvic pain, vesico-uretral dyssynergies. Studies are still needed to improve the selection of ideal candidates, identify prognostic factors and reduce the rate of complications and revisions.
  
  
  METHODS
  4.
authors.affiliation: Service d'urologie, d'andrologie, et de transplantation rénale, CHU Bordeaux Pellegrin, place Amélie-Raba-Léon, 33076 Bordeaux cedex, France. Electronic address: laurence-donon@hotmail.fr.
authors.forename: L
authors.initials: L
authors.lastname: Donon
authors.affiliation: Service d'urologie, d'andrologie, et de transplantation rénale, CHU Bordeaux Pellegrin, place Amélie-Raba-Léon, 33076 Bordeaux cedex, France.
authors.forename: G
authors.initials: G
authors.lastname: Robert
authors.affiliation: Service d'urologie, d'andrologie, et de transplantation rénale, CHU Bordeaux Pellegrin, place Amélie-Raba-Léon, 33076 Bordeaux cedex, France.
authors.forename: P
authors.initials: P
authors.lastname: Ballanger
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D004599:Electric Stimulation Therapy; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D012189:Retrospective Studies; D012445:Sacrococcygeal Region; D001745:Urinary Bladder Diseases / Q000628:therapy*; D014555:Urination Disorders / Q000628:therapy*; D055815:Young Adult
keywords: Hyperactivité vésicale; Incontinence par impériosité; Neuromodulation sacrée; Overactive bladder; Rétention urinaire; Sacral neuromodulation (no MeSH); Urinary retention; Urinary urge incontience